Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Benzonatate Soft Capsule in Healthy Chinese Subjects
NCT03922373Phase 1Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Sep 2018
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of benzonatate in cough (3 arms), sponsored by CSPC ZhongQi Pharmaceutical Technology. Primary endpoints: Time to Maximum Plasma Concentration at Day 4, Maximum Plasma Concentration at Day 4 and 4 more. Status: unknown.
02
Drugs
benzonatate
03
Conditions
cough
Beyond the preview
Go deeper on NCT03922373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03922373.